148 related articles for article (PubMed ID: 6608094)
1. Autologous rosette formation in systemic lupus erythematosus.
Bodolay E; Szegedi G
Acta Med Hung; 1983; 40(2-3):81-9. PubMed ID: 6608094
[TBL] [Abstract][Full Text] [Related]
2. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
Nakai H; Morito T; Tanimoto K; Horiuchi Y
J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
[TBL] [Abstract][Full Text] [Related]
3. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
4. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
6. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
[TBL] [Abstract][Full Text] [Related]
7. Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor.
Palacios R; Alarcón-Segovia D; Llorente L; Ruíz-Arguelles A; Díaz-Jouanen E
J Clin Lab Immunol; 1981 Mar; 5(2):71-80. PubMed ID: 6971333
[TBL] [Abstract][Full Text] [Related]
8. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
[TBL] [Abstract][Full Text] [Related]
9. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
Michalevicz R; Many A; Ramot B; Trainin N
Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
[TBL] [Abstract][Full Text] [Related]
10. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
Medof ME; Oger JJ; Antel JP; Prince GM
J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
[TBL] [Abstract][Full Text] [Related]
11. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
13. Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus.
Kumagai S; Sredni B; House S; Steinberg AD; Green I
J Immunol; 1982 Jan; 128(1):258-62. PubMed ID: 6976374
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
[TBL] [Abstract][Full Text] [Related]
15. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
16. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
17. Effects of lymphocytotoxins of systemic lupus erythematosus (SLE) sera on T and B lymphocytes.
Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
Acta Med Acad Sci Hung; 1975; 32(1):43-8. PubMed ID: 1086049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of some lymphocyte markers in B-cell chronic lymphocytic leukaemia and systemic lupus erythematosus (the B lymphocyte subset).
Magyarlaki T; Losonczy H; Pár A
Haematologia (Budap); 1990; 23(2):111-20. PubMed ID: 2148733
[TBL] [Abstract][Full Text] [Related]
19. Alpha-naphthyl-acetate-esterase reaction for peripheral lymphocytes and monocytes of patients with systemic lupus erythematosus.
Bodolay E; Boros P; Szegedi G
Acta Med Acad Sci Hung; 1982; 39(3-4):145-53. PubMed ID: 6985241
[TBL] [Abstract][Full Text] [Related]
20. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
